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Kaposi Sarcoma (KS) is a rare chronic neoplasm characterized by
a proliferation of vascular endothelial and lymphoreticular cells.1 It
was ﬁrst described by Moritz Kaposi in 1872. Sung et al. 2 in 1997
classiﬁed this pathology into four types: classic or Mediterranean,
African or endemic, iatrogenic or drug associated, and Acquired
Immunodeﬁciency Syndrome (AIDS) -related Kaposi’s sarcoma.
Mediterranean KS is rare. We report a case of fatal classic KS orig-
inal by the multiplicity of organ involvement and typical ﬁndings of
KS in patient with AIDS in spite of not presenting this syndrome.3. Case report
A 50-year-old man presented to our hospital for a one-year
history of cutaneous nodules of the lower limbs, dysuria, dry cough,
chest pain and asthenia. The patient was a 20 pack-year smoker. He
had no drug abuse and he was not homosexual.
On physical examination, the patient was afebrile. There were
multiple coalescing, ﬁrm, purple-blue and reddish-brown plaques
and nodules, pigmented in some areas with sizes ranging from 1 to
7 cm (Fig. 1). These lesions were located on the superior and infe-
rior limbs, the trunk, the hands, the feet, and on the eyelids. There
also was a reddish-brown plaque on the palate and another one on
the oropharynx topped by an ulcerated nodule. Pulmonary exam-
ination revealed bibasal crackles. The arterial blood pressure was
120/60 mmHg. There was a turgescence of the jugular veins,þ216 71 821.184.
.
rved.a hepatomegaly and lower limbs oedema. There were mobile and
non sensitive inguinal and axillar bilateral adenopathies, 1 cm in
size.
On biology, white blood cell count was 7100/mm3, hemoglobin
was 10.7 g/dl, platelet count was 343000/mm3, creatinine was
73 mmol/l, C-reactive protein was 9 mg/l, sedimentation rate was
120 mm, hepatic function and urinary ionogram were normal.
Pathologic skin lesion study revealed features compatible with
KS. Human immunodeﬁciency virus (HIV) serology was negative.
Serology of the human herpes virus 8 (HHV-8) was positive. Ure-
trscopy showed ﬁndings compatible with KS. The patient had
endoscopic ureteral dilatation after which he had no more dysuria.
A chest X-ray ﬁlm (Fig.2) revealed bilateral opacities, car-
diomegaly and left pleural opacity. Electrocardiogram revealed
a low voltage and negative T waves in the anterior precordial
derivations. Heart ultrasound was performed and showed abun-
dant compressive pericarditis. The pericardial drainage yielded
1400 ml of ﬂuid. Oxygen saturation on air-room breathing was
100%.
Fiberoptic bronchoscopy showed an enlarged bifurcation
between the right lower bronchus and the apical segment of the
right lower lobe and enlarged bifurcation between the culmen and
the lingua. Biopsies of these bifurcations showed an inﬂammatory
mucosa. Bronchoalveolar lavage ﬂuid revealed: total cell number:
210.000/ml, macrophages: 81%, lymphocytes: 15%, neutrophil
granulocytes: 3%, eosinophil granulocytes: 1% and Golde score: 0.
Acid fast bacilli were absent from the sputum and the bronchial
ﬂuid. Thoracic CT scan (Fig.3) showed diffuse, bilateral parenchymal
nodules with an average size of 1 cm predominating in the right
lung and beneath the pleura associated to septal thickening, peri-
bronchovascular nodular opacities of the lower right lobe and
multiple atelectasis with traction bronchiectasis of the left lower
lobe. Bilateral axillar adenomegalies were present. There was
Fig. 1. Multiple coalescing, purple-blue and reddish-brown plaques and nodules of the
skin. Fig. 3. Thoracic CT scan: diffuse, bilateral parenchymal nodules associated to septal
thickening and peribronchovascular nodular opacities.
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spleen was enlarged and homogeneous and there was a heteroge-
neous left mass of the subrenal capsule. The liver showed deceased
density in the segments V, VII and VIII. Abdominal ultrasound
revealed a homogeneous enlarged liver with a slightly enlarged
spleen.
During his hospitalization, the patient presented melenae.
Digestive ﬁbroscopy of the upper digestive tract showed macro-
scopic duodenal aspects compatible with KS. Coloscopy was
normal.
The patient was treated by cryotherapy for his skin lesions and
by 3 cycles of chemotherapy consisting on bleomycin: 5 mg/day
during 3 consecutive days, each 15 days. The treatment started on
July 2008.After chemotherapy, the patient became asymptomatic.
The skin lesions diminished dramatically and chest X-ray ﬁlm was
with no abnormality.
A control chest CT scan done on January 2009 when the patient
was asymptomatic revealed a worsening of the interstitial lung
disease and the presence of bilateral pleural effusion. Moreover,
a vertebral lacuna was noted. On February 2009, the patient wasFig. 2. Chest X-ray ﬁlm: bilateral opacities, cardiomegaly and left pleural opacity.admitted for fever and abdominal pain. Physical examination
revealed: temperature at 40 C, left basal crackles, skin lesions
resembling the ancient ones in the upper and lower limbs, an
ulcerated reddish-brown papules on the right eyelid and bilateral
axillar adenopathies. Chest X-ray ﬁlm revealed bibasal alveolar
consolidation. Biological blood analysis revealed inﬂammatory
syndrome. Hemocultures were positive to streptococcus pneu-
monia. Cardiac ultrasonography showed a pericardial non-
constrictive effusion. The patient was administered amoxicillin-
clavulanic acid 3 g per day. The patient became then asymptomatic
with normal chest X-ray ﬁlm and no inﬂammatory syndrome. One
month after this episode the patient received 4 other cycles of
bleomycin after which skin lesions improved dramatically and the
eyelid papule completely disappeared.
On July 2009, he was admitted again in our hospital for dyspnea,
abdominal pain and dysuria anorexia, asthenia and weight loss.
Physical examination revealed a fever at 38.5 C, respiratory
frequency at 24cycles/mn, bilateral crackles, cervical adenopathies,
a splenomegaly, and a relapse of the skin lesions. Blood gas analysis
showed: PH: 7.39, Pa O2: 43 mm Hg, Pa CO2: 27 mmHg, HCO3:
17.9 mmol/l, Sa O2: 82.8%. Chest X-ray ﬁlm showed bilateral
nodules, a right paracardiac opacity and an opacity compatiblewith
a left pleural effusion. White blood cell count was: 5200/mm3. The
patient was administered oxygen therapy and cefotaxim. Two days
later he died from respiratory failure.
3. Discussion
KS is a rare chronic neoplasm. A virus belonging to the herpes
family: HHV-8, also called Kaposi sarcoma herpes virus (KSHV), has
been identiﬁed as the probable cause of this disease.3,4 This virus is
essential but not sufﬁcient for KS development.5 Our patient had
a positive serology for HHV-8. Mediterranean KS typically occurs in
men of Mediterranean and Eastern European background. It has
a male predominance with a male-to-female ratio of 10–15:1 and
the age of onset is between 50 and 70 years.6 It usually follows an
indolent disease of probably low malignant potential and the
lesions localize mainly on the lower extremities and affect the skin
and the subcutaneous tissue.5 In contrast, AIDS-KS is a fulminant
disease, frequently involving several organs, that requires aggres-
sive pharmacotherapy with poor prognosis especially when it
involves visceral organs.7 In our patient, we think that KS corre-
sponds to the classic one as the patient is a male, from Tunisia
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the age of 50. Moreover, the patient did not take any drug or have
any medical care before symptoms and he was HIV negative,
eliminating therefore iatrogenic or drug induced or AIDS-KS. Our
case report is original because of the multi-organ location of the
disease in an HIV negative patient and the fatal outcome of the
disease in an HIV negative patient. In fact, in classic KS, there is
rarely lymph node, mucous membrane, or visceral involvement.8
Diffuse KS in immuno-competent patients was seldom reported in
the literature.9 Most reported cases of KS concern AIDS-KS. We
report an exceptional presentation of the disease.
In classic KS, skin lesions are represented by violaceous reddish
eythemato-angiomatous plaques, papulo-nodular tumefactions
and hard inﬁltration realizing the Kaposi elephantiasis.
Pulmonary KS can involve thoracic structures such as the lung
parenchyma, airways, pleura, and intrathoracic lymph nodes.
Symptoms such as breathlessness, cough, fever, and wheezing are
nonspeciﬁc. Hemoptysis may occur but is unusual. Pulmonary KS
may progress even as mucocutaneous lesions regress.10 This
tropism of KS to the lung may be related to the immunology and
pathogenesis of the HHV-8. Lung involvement is associated with
poor prognosis.
The typical CT ﬁndings of AIDS-related KS include bilateral ill-
deﬁned nodular opacities in a peribronchovascular distribution and
peribronchovascular and interlobular septal thickening.11,12,13 Areas
of ground-glass attenuation surrounding one or more nodules, the
so-called halo sign, have also been described.13,14 These ﬁndings
reﬂect the propensity of KS to inﬁltrate predominately the perihilar
peribronchovascular interstitium. Larger masses and cavities may
be seen but are less common.15 Pleural effusions and, less
commonly, adenopathy may be identiﬁed.11,13,15,16 However, Kha-
lil,17 in a series of 53 intrathoracic KS, found that tumoral masses
and pleural effusions were among the dominating CT features
present in more than 50% cases. In our patient pleural effusion was
a CT ﬁnding. Mediastinal adenopathies were however not be
revealed. The majority of the tumoral masses had proximal air
bronchograms, called pseudoalveolar masses. Like our patient,
some patients had pericardial effusion, associated or not with
pleural effusion. These main CT scan ﬁndings were associated in
66%.17 The author found that the association of these ﬁndings is
very characteristic. Rarely, HRCT scan can show areas of ground-
glass attenuation with superimposed septal thickening (‘‘crazy-
paving’’ pattern).18 Occasionally, patients with pulmonary KS pre-
senting hemoptysis may show patchy ground-glass attenuation
caused by hemorrhage. Sternum, ribs, thoracic spine, and subcu-
taneous involvement of KS have also been described in HIV positive
patients.16 Despite being HIV negative, our patient presented
a vertebral lacuna thought, regarding to the context, to be related to
KS. Therefore, our patient presents the majority of the character-
istic ﬁndings described on CT with the same distribution of the CT
ﬁndings than those in AIDS patients.
The endobronchial KS lesion has a characteristic red or purple
macular or papular appearance, often located at airway bifurca-
tions. Classic violaceous endobronchial plaques may be seen
bronchoscopically. Typically, the lesions are located at airway
bifurcations. Cicenia 19 tried the narrow band imaging which is
a novel endoscopic technique that enhances blood vessel
morphology within the bronchial airway mucosa in 4 patients with
KS. He found that the technique allowed for better delineation of
typical ﬁndings in Kaposi’s sarcoma, and allowed for better differ-
entiation from adjacent areas of chronic inﬂammation. However,
more studies are required to determine the real value of this
method. A diagnostic yield of 24–60% has been reported for
transbronchial lung biopsy for the diagnosis of KS.20 The major
pathologic differential diagnoses include vascular proliferationsand inﬂammatory processes.20 However, lung parenchymal lesions
may occur in the absence of tracheobronchial lesions, and the
diagnosis is therefore often considered if the clinical and radio-
graphic picture is suggestive of the disease.20
Radiotherapy is indicated for localized skin lesions.21 In case of
visceral involvement, symptomatic course or fast progression of KS,
chemotherapy is mandatory. It has a 76% response rate.21
Responses can be reliably obtained with vinblastine,22,23,24 bleo-
mycin, doxorubicin, and dacarbazine alone or in combination.9
Brambilla 25 recommends the combination of vinblastine and
bleomycin as ﬁrst line chemotherapy for advanced KS. Some
authors 26 used the interferon alpha 2b locally with success and
proposed this treatment as an alternative to chemotherapy.
However, this drug may result in serious side effects. Hyperthermic
perfusion (40 C) of the affected limb with tumor necrosis factor
a and melphalan for a period of 90 min, has been shown as having
a favorable effect. However, it has been tried in only 5 patients
which does not allow recommendations.27 Classic KS is generally
an indolent disease which usually requires a less aggressive ther-
apeutic approach than in the African and AIDS-related types of
KS.21 It does not lead to metastasis. The disease-related mortality is
estimated at 4%.21 We treated our patient ﬁrst with 3 cycles of
bleomycin with good results. He relapsed 6 months later when he
presented pneumonia. Twomonths later he received 4 other cycles
of the same drug with favourable outcome. However, the patient
relapsed again 6 months later ha had respiratory insufﬁciency from
which he died.4. Conclusion
KS is a rare chronic neoplasm probably caused by HHV-8. The
Mediterranean or classic form affects subjects in certain geographic
areas not infected by HIV. Skin macroscopic lesions, chest CT scan
ﬁndings when the thorax is involved, endoscopic aspects and
pathologic study make the diagnosis. The treatment is based on
chemotherapy in the disseminated forms. The outcome is in
general favourable. Our patient has an exceptional presentation as
he is immuno-competent and presents the disseminated form of
the disease with a fatal outcome.
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